Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NET DNA scaffold refers to the decondensed nuclear chromatin that forms the backbone of neutrophil extracellular traps (NETs). During NETosis, neutrophils extrude chromatin fibers (mainly DNA with histones and associated cytotoxic enzymes) into the extracellular space, where they function to trap and neutralize pathogens but can also promote inflammation, thrombosis, and tissue damage. This DNA scaffold is essential for immobilizing microbes, providing a structural base for localized high concentrations of toxic proteins, and serving as a stimulus for coagulation and inflammatory signaling. Excess or defective clearance of NET DNA scaffolds is implicated in autoimmunity, thrombosis, cancer progression, and a variety of inflammatory diseases[1][2][3][4][5][6][8].
DNase digests extracellular DNA scaffold, preventing NET-mediated trapping, thrombosis, and tissue injury. Heparin destabilizes the NET scaffold and increases its clearance. PAD4 inhibition prevents histone citrullination, thus inhibiting chromatin decondensation and NET formation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil extracellular trap DNA scaffold (NET DNA).